The Centers for Medicare & Medicaid Services will reweight the cost performance category for the Merit-based Incentive Payment System from 15% to 0% for the 2020 performance period — which affects 2022 payments — due to the impact of the COVID-19 public health emergency, and redistribute the 15% prescribed weight to another performance category or categories. 

“Our analysis of the underlying data for the 2020 performance year, in comparison to prior years’ data, shows that the volume of data available to calculate the scores for the cost measures has significantly decreased overall,” CMS said. “As a result, we do not believe we can reliably calculate scores for the cost measures that would adequately capture and reflect the performance of MIPS eligible clinicians.”

Because the cost performance category relies on administrative claims data, clinicians do not need to take any action, CMS said. For more on the Quality Payment Program, visit the QPP website
 

Related News Articles

Headline
In a report this week, the Department of Health and Human Services’ Office of Inspector General identified 15 drug codes that in third-quarter 2022 met…
Blog
Understanding potential costs is an important part of the patient experience when planning for care, and hospitals and health systems are committed to helping…
Headline
The U.S. health care system spent $60 billion conducting nine common administrative transactions in 2022, about $18 billion more than the previous year due to…
Perspective
Most of us need the services of a hospital at some point in our lives. And hospitals and health systems have never wavered from their mission of keeping people…
Chairperson's File
On this episode, I talk with Julie Yaroch, D.O., president of ProMedica Charles and Virginia Hickman Hospital in Adrian, Mich. Julie and I discuss the issues…
Headline
U.S. spending on health care declined for the first time in 60 years in first-quarter 2022, falling 1.7% year over year as health care prices fell relative to…